Skip to content
Screener

Novanta NOVT Medical Solutions — Cost of Goods Sold

Similar metrics at other companies

Methode Electronics logo
MEIMedical — Cost of Goods Sold
$0
Gentherm logo
THRMMedical Segments — Cost of Goods Sold
$7.05M+23.0%
Neuronetics logo
STIMMedical Device — Cost of Goods Sold
$2.86M-9.3%
Entravision Communications, Inc. logo
EVCMedia — Cost of Goods Sold
$6.06M+30.4%
TE Connectivity logo
TELIndustrial Solutions — Cost of Goods Sold
$1.45B+23.6%
TE Connectivity logo
TELTransportation Solutions — Cost of Goods Sold
$1.55B+2.5%

Other financials

Income statement

See full
Revenue$265.8M+10.3%
Gross profit$120.9M+13.3%
Operating income$18.1M+21.1%
Net income$12.5M+179%
EPS (diluted)$0.30+150%

Balance sheet

See full
Cash & equivalents$718.7M+554%
Total debt$285.6M-44.5%
Total equity$1.6B+102%
Total assets$2.1B+41.6%

Cash flow

See full
Operating cash flow$64.9M+331%
CapEx$7.5M+120%
Free cash flow$57.5M+392%

Valuation

See full
Market cap$6.29B+54.6%
Enterprise value$5.86B+30.9%
P/E101.9×+35.5×
P/S6.1×+1.9×

Profitability

See full
Gross margin44.5%-0.2pp
Operating margin9%-2.2pp
Net margin6%-0.4pp
FCF margin11.1%-1.2pp

Returns & leverage

See full
Return on equity5.1%-3.1pp
Debt / equity0.2×-0.5×
Current ratio4.6×+2.0×

Where this comes from

Reported directly by Novanta in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The source filing: Novanta’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:00 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335404
Line itemThree Months Ended July 3, 2026 / Automation Enabling TechnologiesThree Months Ended July 3, 2026 / Medical SolutionsThree Months Ended July 3, 2026 / TotalSix Months Ended July 3, 2026 / Automation Enabling TechnologiesSix Months Ended July 3, 2026 / Medical SolutionsSix Months Ended July 3, 2026 / Total
Revenue$136,215$129,592$265,807$267,459$256,055$523,514
Cost of revenue63,41976,714130,707148,443
Amortization of purchased intangible assets1,2002,5552,4005,114
Segment gross profit71,59650,323121,919134,352102,498236,850
Research and development and engineering9,49614,66718,52828,915
Selling, general and administrative20,78416,58540,67332,891
Amortization of purchased intangible assets2,7043,7114,8237,366
Restructuring, acquisition, and related costs2,0201,7532,5832,993

Item 1. Financial Statements

FAQ

What is Novanta's medical solutions — cost of goods sold?
Novanta (NOVT) reported medical solutions — cost of goods sold of $76.71M in Q2 2026.
How has Novanta's medical solutions — cost of goods sold changed year-over-year?
Novanta's medical solutions — cost of goods sold increased by 14.5% year-over-year, from $66.97M to $76.71M.
What is the long-term trend for Novanta's medical solutions — cost of goods sold?
Over 3 years (2022 to 2025), Novanta's medical solutions — cost of goods sold has grown at a 14.0% compound annual growth rate (CAGR), from $181.91M to $269.36M.
What does medical solutions — cost of goods sold mean?
The direct costs attributable to the production of goods and the delivery of services within the Medical Solutions segment. This includes raw materials, direct labor, and manufacturing overhead required to generate the segment's revenue.

Ask your AI about Novanta's medical solutions — cost of goods sold.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude